Member Info for EmeraldCarrots

Cross their fingers and pray the baby won't be rendered deaf when they administer aminoglycoside antibiotics in the neonatal ward? I wonder what the staff think of this situation. What do they say to the parents if this happens. "Sorry, you were unlucky? If only we had the Genedrive(R) MT-RNR1 ID, but we don't, yet. We will probaby be getting it though............". The staff should insist on it............ I'm sure the parents would but they are probably unaware!

To have a substantial share holding. Come on........ you don't really have any shares in GDR do you? If you do and what you post is really your opinion of them then you are a complete idiot. Total.

"Use of proceeds.

The net proceeds from the Subscription will provide genedrive with additional working capital as it actively pursues a broad range of growing commercial opportunities in the UK and internationally at the present time, including both commercial sales and potential non-dilutive grant income. CE-IVD certification for genedrive's CYP2C19 test, which is on track for April 2025, will also enable in-country registration and subsequently sales of the test to commence outside of the UK and genedrive is

****particularly encouraged by opportunities presented in the Middle East region, where it has focused significant efforts and expenditure to understand market access and reimbursement routes as well as identification of primary target hospitals, opinion leaders and healthcare organisations and will update further in due course as opportunities are converted as appropriate****.

The Subscription provides the Company with an extended cash runway to seek to close a number of the commercial and other opportunities in front of it and further drive shareholder value. The Board will continue to assess longer term financing options in the meantime."

===============================

4 months ago. With no RNS's since 31/05/2025 we simply don't know. Could be bad, could be good. Obviously they were optimistic of sales in the Middle East.

Machines in regular use in the UK's NHS. Genedrive(R) MT-RNR1 ID in use at 16 hospitals now, and that should be 21 + 15 = 36 in 6 months time assuming not one more order arrives in the next 6 months, which seems unlikely. Both machines now certified for use in the EU. 15,000 hospitals in the EU!!! 1,500 in the UK and 6,000 in the USA. The the rest of the World. erm.....?

USA to come too!

All IMHO.

1. Part way through installing the Genedrive® MT-RNR1 in 14 hospitals for the NHS England long term evaluation test. 9 confirmed up and running to 31st May. Where are we now? No RNS, so no clue!

2. Scottish roll out of the Genedrive® MT-RNR1. There are 15 neonatal Hospitals in Scotland. Installations to start in October as per the Scottish Government announcement. Planning and procurement must be starting about now. It's now August so 2 months to go. If they do have at least 2 machines as I suspect (Brighton has 2 as they are in one of the pictures) they will be installing about 30 machines. On installation the consumables will need to be in stock at the hospital.

3. Genedrive CYP2C19-ID Kit. RNS dated 13th May 2025. Order valued at approx £120,000 to install machines in Manchester to evaluate their use in Acute Coronary Syndrome.

All machines once installed will provide regular income for Genedrive for years to come.

I believe the Genedrive® MT-RNR1 is in use at 16 hospitals at the moment. This includes trusts that have chosen not to wait for the result of the long term test NICE decided to do and bought the machine anyway.

All IMHO.

Smithfields

"Is this a problem?"

https://www.msn.com/en-gb/health/other/new-revolutionary-test-trial-aims-to-detect-10-cancers-at-earliest-stage/ar-AA1Jocid=hpmsn&cvid=8b663771e1664f90a7b411956119f187&ei=43

==================

No. You need to have cancer to have circulating tumour cells (CTC's) in your blood. Parsortix is valuable as it can catch live, intact CTC's for analysis. If a Grail or other CtDna test indicates someone MIGHT have cancer (they are not that accurate) then Parsortix might be used to help confirm the cancer, or indeed confirm it is not trying to spread......... yet. As they are live and intact, they have DNA, RNA and protein expression of the cell all of which can be tested. Ideal for DNA testing in fact which is why dual analysis should take off.

Grail is one of the Companies that might decide to buy Angle Plc. Adding CTC analysis would make their test more accurate providing loads more information. I suspect they prefer to push the sales side of their test as it sells, even though a positive indication of possible cancer would need further investigation as their small print says. It's all money money money...... If it sells, sell it. Even if it's far from perfect and indeed could be improved.

All IMHO.

Correction:-

Significantly down on (over 50% at least). This is good! Obviously this will increase the drive to profitability and I hope frankly get rid of any underperforming staff, if there are any. I think their sales side is underperforming to say the least. Sales to the EU?? A machine that can test a baby won't have a bad reaction to antibiotics and stop it from possibly going stone deaf! How can a sales person not get sales with that sort of ammunition!! Only a very, very bad one I suggest.

All IMHO.

Significantly down on (over 50% at least). This is good. Obviously this will increase the drive to profitability and I hope frankly get brid of any underperforming staff, if there are any. I think their sales side in underperforming to say the least. Sales to the EU??

All IMHO.

Up 4.26%

Because we don't have any holder with over 3%! Or they would have had to declare the holding in an RNS. In a way it's good. Also no big holder to block a bid........ Big holders usually try to stabilise the sp by buying/selling when there is good/bad news. That makes this share more fun.

Take a photo quick! LOL!

Costing £32,000.

@ 1.2p they are now worth £12,000. So a loss of £20,000. Oh dear.

Him amd other directors also bought at around 2.2p a share, now anout 50 % down.

At least they are involved now. Might spur them on................ I certainl hope so.

Things are a lot better now........ miles better.

https://www.lse.co.uk/rns/GDR/directorpdmr-shareholding-fpcpxly1q4uetox.html

JimiHendrix.

Promising but I doubt there’s much market for a rapid test in the antidepressant prescription world, I’m sure there are some niche circumstances or settings but generally labs can probably handle those imo.

======================================

Hello. Why wait for a lab test when it's more expensive and takes days. Wake up. Do you work for the NHS? Maybe you are used to days/weeks? Most people want "Now" and don't want to wait days/weeks especially if it costs more!

Via Angle plc's dual analysis but the industry does not care. Dual analysis should double the amount of patients eligible but no-one gives a **it. Shameful. This should be in the national newspapers to shame the big Plc's like Astrazeneca IMHO.

So, Angle prove that with dual analysis about double the number can be found (RNS dated 4th Jan 2024). Then the industry does NOTHING as far as doing a cancer drug (test validation?) trial. How on earth could this validation trial fail? It's been tested in the lab with blood from people with cancer so it is not necessary surely? Something is very wrong here. Illumina definitely is interested as Angle have confirmed. Indeed, they have developed an assay that is for lung cancer dual analysis. Roche is rumoured to be interested. What is the matter with all these Companies?

All IMHO.

So Angle proove that with dual analysis about double the number can be found. The the industry does NOTHING

Antidepressant. In the UK, in the EU, in the USA, in the World. Big enough?

I think Genedrive should buy a bulk load of them. Some for research and some to free issue to their shareholders. LOL!

New installations. Work from existing orders that is/will vastly increase the amount of machines in use (to at least 62 by my calculations). Sales value of 62 machines is at least £5000 x 62 = £310,000. Then every time a test is done consumables are used. Is that £100 each time? So that is/will be REGULAR INCOME for the foreseeable future. As in years and years. The fuss about the other machine possibly being recommended for a Nationwide UK rollout in 2 weeks is all very well but actual orders are what counts.

All IMHO.

The hospitals that use the machines have at least two. which is significant. ***The two are shown in this article***. At least 16 hospitals using as confirmed in the RNS's up until the last one on 31/05/2025 (six weeks ago). So at least 32 machines. 15 neonatal hospitals in Scotland, so another 30 machine sales to come. Total *****62***** !!!!!

https://www.uhsussex.nhs.uk/news/an-innovative-genetic-test-launches-in-brighton-to-help-prevent-hearing-loss-in-vulnerable-newborns/